Ben Taylor comes to Recursion after over 4 years as the CFO of Exscientia. Ben has more than two decades of experience in healthcare investment banking and executive roles, including 15 years at Goldman Sachs and Barclays in the U.S., Asia and Europe. During this period, Ben focused on financing, strategic and cross-border transactions in the biopharmaceutical industry. Ben served as President and CFO for Tyme Technologies, a NASDAQ-listed oncology focused biotechnology company, where he oversaw the company’s advancement from Phase 1 to Phase 3. Prior to joining Exscientia, Ben was interim CFO at Aetion, a healthtech company using real world data analytics to optimise biopharma clinical development and commercialisation.
